|
Lipid and lipoprotein metabolism
Citations 211-220 of 547 total displayed.
|
Past content
(since Jan 1999):
|
- Epidemiology
Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study
- Rudy Guerra, Zhaoxia Yu, Santica Marcovina, Ronald Peshock, Jonathan C. Cohen, and Helen H. Hobbs
Circulation 2005;111:1471-1479; published online before print as doi:10.1161/01.CIR.0000159263.50305.BD
[Abstract]
[Full text]
- Vascular Medicine
Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits
- Stephen J. Nicholls, Gregory J. Dusting, Belinda Cutri, Shisan Bao, Grant R. Drummond, Kerry-Anne Rye, and Philip J. Barter
Circulation 2005;111:1543-1550; published online before print as doi:10.1161/01.CIR.0000159351.95399.50
[Abstract]
[Full text]
- Articles
Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits
- Stephen J. Nicholls, Gregory J. Dusting, Belinda Cutri, Shisan Bao, Grant R. Drummond, Kerry-Anne Rye, and Philip J. Barter
Circulation published March 21, 2005, doi:10.1161/01.CIR.0000159351.95399.50
[Abstract]
- Articles
Lipoprotein(a) and Apolipoprotein(a) Isoforms. No Association With Coronary Artery Calcification in The Dallas Heart Study
- Rudy Guerra, Zhaoxia Yu, Santica Marcovina, Ronald Peshock, Jonathan C. Cohen, and Helen H. Hobbs
Circulation published March 21, 2005, doi:10.1161/01.CIR.0000159263.50305.BD
[Abstract]
- Epidemiology
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors: The Ludwigshafen Risk and Cardiovascular Health Study
- Karl Winkler, Bernhard R. Winkelmann, Hubert Scharnagl, Michael M. Hoffmann, Andrea Busse Grawitz, Markus Nauck, Bernhard O. Böhm, and Winfried März
Circulation 2005;111:980-987; published online before print as doi:10.1161/01.CIR.0000156457.35971.C8
[Abstract]
[Full text]
- Vascular Medicine
Systemic Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Inflammation and Improves Vascular Function in Hypercholesterolemia
- Rajesh K. Kharbanda, Sharon Wallace, Benjamin Walton, Ann Donald, Jennifer M. Cross, and John Deanfield
Circulation 2005;111:804-807; published online before print as doi:10.1161/01.CIR.0000155236.25081.9B
[Abstract]
[Full text]
- Articles
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors. The Ludwigshafen Risk and Cardiovascular Health Study
- Karl Winkler, Bernhard R. Winkelmann, Hubert Scharnagl, Michael M. Hoffmann, Andrea Busse Grawitz, Markus Nauck, Bernhard O. Böhm, and Winfried März
Circulation published February 14, 2005, doi:10.1161/01.CIR.0000156457.35971.C8
[Abstract]
- Cardiology Patient Pages
The "Good Cholesterol": High-Density Lipoprotein
- Peter P. Toth
Circulation 2005;111:e89-91e, doi:10.1161/01.CIR.0000154555.07002.CA
[Full text]
- Articles
Systemic Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Inflammation and Improves Vascular Function in Hypercholesterolemia
- Rajesh K. Kharbanda, Sharon Wallace, Benjamin Walton, Ann Donald, Jennifer M. Cross, and John Deanfield
Circulation published February 7, 2005, doi:10.1161/01.CIR.0000155236.25081.9B
[Abstract]
- Coronary Heart Disease
Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients
- Valerio Sanguigni, Pasquale Pignatelli, Luisa Lenti, Domenico Ferro, Alfonso Bellia, Roberto Carnevale, Manfredi Tesauro, Roberto Sorge, Renato Lauro, and Francesco Violi
Circulation 2005;111:412-419, doi:10.1161/01.CIR.0000153810.81187.7D
[Abstract]
[Full text]
|
|
